TAXIS PHARMACEUTICALS
TAXIS Pharmaceuticals is a privately held biopharmaceutical company dedicated to developing compounds to target the growing threat of antimicrobial resistance, including antibacterial and antiviral resistance. We are currently focused on antibiotic agents that employ novel mechanisms of action distinct from those currently in clinical use. Our team’s expertise in discovery chemistry, combined with our spirit of innovation, allows us to quickly pinpoint promising compounds that exhibit the key properties required for a clinical drug candidate.
TAXIS PHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2009-01-01
Address:
Monmouth Junction, New Jersey, United States
Country:
United States
Website Url:
http://www.taxispharma.com
Total Employee:
1+
Status:
Active
Contact:
(732)230-3074
Total Funding:
8.9 M USD
Technology used in webpage:
Google Google Cloud
Similar Organizations
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Jeil Pharmaceutical
Jeil Pharmaceutical is a contributed to the growth and development of the pharmaceutical industry.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Current Employees Featured
Founder
Investors List
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases investment in Grant - TAXIS Pharmaceuticals
CARB-X
CARB-X investment in Grant - TAXIS Pharmaceuticals
Official Site Inspections
http://www.taxispharma.com Semrush global rank: 9.68 M Semrush visits lastest month: 331
- Host name: server3.bowerwebsolutions.com
- IP address: 67.227.237.65
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
More informations about "TAXIS Pharmaceuticals"
About – TAXIS Pharmaceuticals
At TAXIS Pharmaceuticals, our mission is clear: to combat antimicrobial resistance and save lives. Antimicrobial resistance demands immediate, coordinated action from governments, …See details»
TAXIS Pharmaceuticals - Crunchbase Company Profile …
TAXIS Pharmaceuticals is a privately held biopharmaceutical company dedicated to developing compounds to target the growing threat of antimicrobial …See details»
TAXIS Pharmaceuticals, Inc. | LinkedIn
TAXIS Pharmaceuticals is a biotech company devoted to combatting the serious and deadly societal threat of antibiotic resistance by creating therapies that address the root cause of the …See details»
TAXIS Pharmaceuticals Company Profile | Management and
Www.taxispharma.com TAXIS Pharmaceuticals Profile and History TAXIS Pharmaceuticals, Inc. is a clinical stage company developing anti-resistance drug candidates that enable the re-use of …See details»
TAXIS PHARMACEUTICALS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TAXIS PHARMACEUTICALS, INC. of Monmouth Junction, NJ. Get the latest business insights from …See details»
TAXIS Pharmaceuticals, Inc. | LinkedIn
TAXIS Pharmaceuticals, Inc. | 190 followers on LinkedIn. Founded in March, 2009, TAXIS Pharmaceuticals is focused on the discovery and development of pharmaceuticals targeting …See details»
TAXIS Pharmaceuticals Inc Overview - Salary.com
Discover essential details about TAXIS Pharmaceuticals Inc, including address, contact, and journey of our company's evolution.See details»
TAXIS Pharmaceuticals - Craft
TAXIS Pharmaceuticals has 5 employees at their 1 location. See insights on TAXIS Pharmaceuticals including office locations, competitors, revenue, financials, executives, …See details»
TAXIS Pharmaceuticals - Products, Competitors, Financials, …
The World Health Organization (WHO) recently named AMR one of the top global public health and development threats. ... Website: www.taxispharma.com. References 2. Antimicrobial …See details»
Latest News and Insights – Taxis Pharmaceuticals
Dr. Kimball served as Vice President of Chemistry at Lexicon Pharmaceuticals, where he was responsible for building an organization of over 75 chemists, including medicinal, analytical, …See details»
TAXIS Pharmaceuticals - Overview, News & Similar companies
Jan 13, 2020 Who is TAXIS Pharmaceuticals. TAXIS Pharmaceuticals, Inc. is a clinical stage company developing anti-resistance drug candidates that enable the re-use of the most widely …See details»
Taxis Pharmaceuticals - PitchBook
Www.taxispharma.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 9 Deerpark Drive; Monmouth Junction, NJ 08852; United …See details»
TAXIS Pharma - Company Profile - Tracxn
Nov 13, 2024 TAXIS Pharma - Specialty developing compounds to target the growing threat of antimicrobial resistance. Raised a total funding of $7.58M over 8 rounds from 3 investors. …See details»
TAXIS Pharmaceuticals
The World Health Organization (WHO) named TXA709 as one of only 2 (out of 26) antibacterials that targets WHO priority pathogens and meets all the WHO innovation criteria (absence of …See details»
CARB-X funds TAXIS Pharmaceuticals to accelerate development …
Jan 8, 2020 [email protected] +1 732 230 3074 About CARB-X Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global non-profit partnership …See details»
TAXIS Pharmaceuticals Announces CARB-X Award of $3.2 Million, …
Jan 14, 2020 Gregory G. Mario, CEO [email protected] www.taxispharma.com TAXIS Pharmaceuticals, Inc. 9 Deerpark Drive Monmouth Junction, NJ 08852 (732) 230-3074 …See details»
What are pharmacy benefit managers? A health economist …
1 day ago James B. Rebitzer does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant …See details»
Pipeline – TAXIS Pharmaceuticals
TAXIS Pharmaceuticals is researching new classes of anti-resistance agents that employ novel mechanisms of action. We are focusing our science on the disruption of the foundation of …See details»
TAXIS acquires novel antimicrobial drug candidates from Biota
According to the World Health Organization, antibiotic resistance represents one of the most pressing global health challenges today. TAXIS research targets two MDR pathogens …See details»
WHO Names TAXIS’ TXA709 as One of Only 2 (out of 26) …
(Monmouth Junction, NJ USA)– On April 15, 2021, the World Health Organization (WHO) released their report titled “2020 Antibacterial Agents in Clinical and Preclinical Development” …See details»